A clinical trial to study the analgesic effect of dexmeditomedine and midazolam with lignocaine for intravenous regional anesthesia

To compare the analgesic efficacy of dexmeditomedine and midazolam when added to lignocaine for intravenous regional anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/08/006142

Enrollment

Registered

2015-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA 1 ASA 2

Interventions

Control Intervention1: dexmeditomedine midazolam: dexmeditomidine 1 mcg/kg midazolam 50 mcg/kg single dose at start of study

Eligibility

Inclusion criteria

Inclusion criteria: normal baseline ECG ASA 1 and 2

Exclusion criteria

Exclusion criteria: patients with history of allergy to local anesthetics patients who are highly nervous and uncooperative patients wiyh crush injury and open wound on hands patients with infection and cellulitis of operative limb patients with history of epilepsy patients with peripheral arterial disease,sickle cell disease,AV malformation patients of ASA 3,4 and 5 pregnancy

Design outcomes

Primary

Measure	Time frame
HEART RATE NON INVASIVE BLOOD PRESSURE MEAN ARTERIAL PRESSURE PARTIAL PRESSURE OF OXYGEN SATURATION Timepoint: o min 5 min 10 min 15 min 20 min 40 min 60 min 90 min	—

Secondary

Measure	Time frame
SEDATION SCORETimepoint: o min 5 min 10 min 15 min 20 min 40 min 60 min 90 min	—

Countries

India

Contacts

Public ContactDR GEETA CHOUDHARY

Dr RPGMC kangra at tanda

ravinderkumar5858@gmail.com8894674909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026